U.S. Office REITs Stock News

Cencora (COR) stock has drawn investor attention after recent trading performance, with the share price closing at $281.43. The move comes alongside mixed short term returns and a longer multi year track record. See our latest analysis for Cencora. Recent trading puts Cencora’s 30 day share price return at 9.20%, yet the stock is still down 16.95% year to date. Longer term total shareholder returns over three and five years remain positive, suggesting recent momentum is rebuilding after a...

Gorman-Rupp (GRC) stock has drawn fresh attention after a strong run over the past year, with total return reported at 141.0%. That performance has prompted closer scrutiny of what is driving the move. See our latest analysis for Gorman-Rupp. Recent momentum in Gorman-Rupp’s share price has been strong, with a 7-day share price return of 9.61% and a year to date share price return of 77.40%, while the 1 year total shareholder return of 141.01% points to sustained investor enthusiasm rather...

SpaceX’s leap to a $2.73t valuation, a 50% share price rally, and a $60b move into AI through its Cursor acquisition have put artificial intelligence firmly back in the spotlight. With fresh options trading and fast-track index inclusion drawing in more capital, many investors are asking which AI stocks could be most exposed to this surge in attention. This article breaks down 3 positively exposed stocks from our AI Sector screener, helping you quickly assess where this news-driven momentum...

If you are wondering whether Bio-Techne stock still offers value at around US$56.17, the recent share performance gives you a useful starting point but not the full story. The stock has risen 6.7% over the past week and 29.7% over the last 30 days, yet it is still down 5.8% year to date and has declined 27.3% over 3 years and 47.8% over 5 years, which can influence how investors think about both its upside potential and risk. Recent coverage of Bio-Techne has focused on its role in life...

On June 4, 2026, Northwest Natural Holding Company and its subsidiary NW Natural Water completed and agreed to private placements of multiple senior notes totaling US$195,000,000, with coupons between 5.15% and 5.83%, staggered maturities out to 2036, and leverage covenants capping indebtedness at 70% of total capitalization. The absence of a parent guarantee on NW Natural Water’s new notes, alongside the use of proceeds to refinance existing borrowings, highlights a deliberate separation of...

Markets are wrestling with what Kevin Warsh’s arrival at the Federal Reserve could mean for interest rates, inflation signals, and the cost of money across the system. With traders now pricing a higher chance of rate hikes, while Warsh talks about trimmed-mean inflation measures and less transparent Fed communication, some financial stocks may be better positioned than others for a world of stickier inflation and elevated Treasury yields. This article highlights three financial sector stocks...

Myers Industries (MYE) has drawn attention after recent share price moves, with the stock last closing at $26.84. Investors are weighing this valuation against the company’s mixed picture on annual revenue and net income. See our latest analysis for Myers Industries. Recent trading in Myers Industries has been choppy, with a small share price pullback in the last day sitting alongside a strong 30 day share price return of 21.39% and a 1 year total shareholder return of 86.26%, suggesting...

If you are wondering whether Service Corporation International stock offers good value at around US$73.96, the answer depends on which valuation lens you use. The share price has risen 3.7% over the past week, but is down 4.9% over the last month and 4.2% year to date, with a 1 year return of a 3.9% decline against longer term gains of 17.4% over 3 years and 52.5% over 5 years. Recent news coverage around Service Corporation International has mainly focused on ongoing industry trends in...

Knight-Swift Transportation Holdings announced that founder and former CEO Kevin P. Knight has retired as Executive Chairman and director, with David Vander Ploeg becoming Chair of the Board, while Knight enters a 24‑month consulting agreement that includes a US$20.25 million fee and post-retirement restrictive covenants. At the same time, Citi shifted to a more cautious view on Knight-Swift and the trucking sector, highlighting muted revenue growth, declining earnings per share, cost...

In recent weeks, StoneCo Ltd. has seen increased attention as analysts raised earnings estimates and highlighted its discounted valuation against industry metrics. This shift in sentiment, anchored by expectations of stronger profitability and revenue growth ahead of the upcoming earnings release, is reframing how investors assess StoneCo’s prospects. Next, we’ll examine how this wave of upward earnings revisions could reshape StoneCo’s existing investment narrative and risk-reward...

HA Sustainable Infrastructure Capital, Inc. recently priced a US$1 billion offering of 5.950% green senior unsecured notes due 2033, with guarantees from several affiliated entities and plans to allocate proceeds toward eligible climate-focused projects after temporarily paying down short-term borrowings. The deal underscores how the company is leaning on green bond markets to fund a growing pipeline of energy transition assets while reshaping its balance sheet and cost of capital. We’ll now...

In June 2026, Ultragenyx Pharmaceutical Inc. filed a US$81.53 million shelf registration for 3,400,000 common shares linked to an employee stock ownership plan and participated in the Goldman Sachs 47th Annual Global Healthcare Conference, where Founder and CEO Emil D. Kakkis presented the company's rare disease and gene therapy focus. These developments come alongside growing attention on Ultragenyx’s gene therapy pipeline and regulatory tailwinds, which are reshaping how investors assess...

NovoCure (NasdaqGS:NVCR) has appointed Frank Leonard to its board of directors. The appointment follows shareholder elections held at the company’s recent annual general meeting. This board change introduces a new voice to NovoCure’s governance during an important period for the business. NovoCure enters this board transition with its stock at $17.6 and a mixed recent track record. The share price is up 4.5% over the past week and 34.1% year to date, while the 1 year return is down 1.7% and...

If you are wondering whether Papa John's International stock at around US$33 is a bargain or a value trap, the starting point is understanding what the current price actually reflects. The share price is up 4.8% over the last week, yet remains down 4.5% over the last month, 17.7% year to date, and 30.2% over the past year. There have also been longer term declines of 49.8% over three years and 63.3% over five years that may influence how investors see its risk and recovery potential. Recent...

If you are wondering whether Peoples Bancorp stock still offers value at around US$35.89, the current pricing sets up an interesting question about what the market is really expecting from the company. Over recent periods, the stock has delivered returns of 1.4% over 7 days, 8.7% over 30 days, 19.0% year to date, 30.4% over 1 year, 50.7% over 3 years, and 53.6% over 5 years. This naturally draws attention to whether the recent share price reflects a fair valuation or not. Recent news...

Global markets are wrestling with mixed signals on inflation, growth, and interest rates, which can make it hard to know where to focus. One approach is to look past headlines and concentrate on companies whose cash flows appear solid yet whose share prices sit below an estimate of fair value. That is what the Undervalued Stocks Based On Cash Flows screener targets, using SWS DCF valuation to flag potential mismatches between price and underlying cash generation. In this article, you will see...

Earlier this month, Summit Therapeutics filed and then withdrew a US$500.00 million follow-on equity offering of 35,435,861 common shares at an indicated US$14.11 price range after announcing positive Phase II/III data for its lead cancer drug ivonescimab in non-small cell lung and metastatic colorectal cancers. The combination of encouraging ivonescimab trial outcomes with a halted equity raise highlights how Summit is balancing funding needs against market conditions as it advances a...

Artificial intelligence is cutting across everything from chips and cloud to everyday software, even as central banks weigh inflation, bond markets react to shifting rate expectations, and growth trends look uneven across major economies. That mix of cost pressures, productivity needs, and cautious corporate budgets is pushing many investors to look for AI stocks with clearer links to real products such as semiconductors, large language models, and AI infrastructure. This AI Stocks screener...

Royal Caribbean Cruises (RCL) stock moved after renewed optimism around international relations, as a high profile diplomatic agreement lifted sentiment toward global travel, with cruise and airline stocks reacting alongside other beneficiaries of cross border activity. See our latest analysis for Royal Caribbean Cruises. Beyond the latest diplomatic news, Royal Caribbean Cruises has been in the spotlight for operational developments such as the new Seward, Alaska terminal and ongoing...

Earlier this week, President Trump canceled planned military strikes on Iran and signaled possible diplomatic progress, easing immediate geopolitical tensions that had weighed on global markets. The news resonated across semiconductor names such as Nova, highlighting how macro-level political decisions can quickly influence sentiment toward globally exposed chip-equipment suppliers. With geopolitical risk easing for now, we’ll examine how this development fits into Nova’s investment...

The United States market has shown a robust performance, climbing 2.2% in the last week and 25% over the past year, with earnings projected to grow by 19% annually in the coming years. In such a thriving environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors looking to capitalize on undervalued assets.

Over the last 7 days, the United States market has risen by 2.2%, and over the past 12 months, it is up by an impressive 25%, with earnings expected to grow by 19% per annum in the coming years. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business's operations and future prospects.

The market has climbed 2.2% in the last 7 days and is up 25% over the past year, with earnings expected to grow by 19% annually in the coming years. In such a robust market, identifying stocks with strong fundamentals and growth potential is key, especially when considering penny stocks—companies that are smaller or less established but can offer significant value. Despite being an outdated term, penny stocks remain a relevant investment area for those seeking opportunities in companies with...

In June 2026, Badger Meter, Inc. amended and extended its US$150,000,000 multi-currency revolving credit facility to July 8, 2031, with no current borrowings and interest tied to its consolidated net debt to EBITDA ratio using benchmark rates like Term SOFR, Adjusted EURIBO and Daily Simple SONIA plus 87.5 basis points. This extended, undrawn credit facility strengthens Badger Meter’s financial flexibility at a time when it is facing multiple securities class action lawsuits over revenue...